RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
RARX
Delisted
RARX was delisted on the 1st of April, 2020.
64 hedge funds and large institutions have $230M invested in Ra Pharmaceuticals, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
64
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$6.34M | |
| 2 | +$4.66M | |
| 3 | +$2.74M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$2.19M |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$1.75M |
Top Sellers
| 1 | -$4.41M | |
| 2 | -$2.48M | |
| 3 | -$1.96M | |
| 4 |
NC
Nexthera Capital
New York
|
-$1.91M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$996K |